ArticleCureus2025
Racial Impact of Hypertension on Colorectal Cancer Screening in Central Illinois, United States.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Colorectal cancer (CRC) is one of the most common types of cancer in the United States. We evaluated the association between hypertension and CRC screening in the American population in Central Illinois. We performed the analysis by investigating the association between hypertension and CRC screening in the American population in Central Illinois, specifically African Americans, to detect disparities. Methods Using electronic medical records from an Illinois healthcare system, we analyzed patients aged 45-75 years between January 2014 and December 2023. The data reviewed included factors such as race, age, gender, education, and hypertension. Race categories were White, African American, and others including Hispanics, Asians, Native Americans, Pacific Islanders, Samoans, and unclassified races. Exclusions were patients outside the age limit or those diagnosed with CRC without screening. We recorded frequencies and percentages for categorical variables and statistical measures for numeric ones. The Pearson chi-squared test evaluated the association between race and CRC screening. Data analysis was performed in R at a 5% significance level. Results Among screened patients, 2,264 (75.4%) African American, 14,446 (52.1%) White, and 650 (48.4%) others had hypertension. Of those testing positive for CRC, 14 (73
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.